MICHAEL-PAUL STETSON: Open Payments
NPI 1831740554 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 12 payments from 9 companies in 2025. Trend: 2023 $576 · 2024 $463 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $101 |
| Janssen Biotech, Inc. | 2 | $62 |
| ABBVIE INC. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $36 |
| Tempus AI, Inc | 1 | $32 |
| Olympus America Inc. | 1 | $20 |
| TOLMAR, INC. | 1 | $19 |
| Endo USA, Inc. | 1 | $17 |
Products named: AMS 700, ERLEADA, KEYTRUDA, Bard Urinary Drainage Bag, XT CDX, LUPRON DEPOT, BOTOX, iTIND System.
Industry payments across NY — which companies pay providers there.
